These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3209057)

  • 1. Cell surface markers and cellular immune response associated with rheumatic heart disease: complex segregation analysis.
    Rich SS; Gray ED; Talbot R; Martin D; Cairns L; Zabriskie JB; Braun D; Regelmann WE
    Genet Epidemiol; 1988; 5(6):463-70. PubMed ID: 3209057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further observations and characterization of monoclonal antibodies reacting with B cell alloantigens associated with rheumatic fever and rheumatic heart disease.
    Kumar D; Kaur S; Grover A; Bali H; Khanduja KL; Kaplan EL; Gray ED; Ganguly NK
    J Lab Clin Med; 2000 Mar; 135(3):287-93. PubMed ID: 10711868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of cells bearing "rheumatic" antigens in peripheral blood of patients with rheumatic fever/rheumatic heart disease.
    Regelmann WE; Talbot R; Cairns L; Martin D; Miller LC; Zabriskie JB; Braun D; Gray ED
    J Rheumatol; 1989 Jul; 16(7):931-5. PubMed ID: 2475627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatic fever and rheumatic heart disease: genetics and pathogenesis.
    Guilherme L; Ramasawmy R; Kalil J
    Scand J Immunol; 2007; 66(2-3):199-207. PubMed ID: 17635797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Some of the people, some of the time: susceptibility to acute rheumatic fever.
    Bryant PA; Robins-Browne R; Carapetis JR; Curtis N
    Circulation; 2009 Feb; 119(5):742-53. PubMed ID: 19204317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte subpopulations in rheumatic heart disease.
    Regelmann WE; Gray ED; Wannamaker LW; Lebien TW; Mansour M; el Kholy A; Abdin Z
    J Rheumatol; 1987 Feb; 14(1):23-7. PubMed ID: 2952796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A new immunogenetic marker of rheumatism].
    Kilasoniia LO; Chumburidze VB; Tatishvili NI; Polianskaia IS; Tsitlanadze VG
    Klin Med (Mosk); 1989 Jun; 67(6):64-6. PubMed ID: 2789313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Presence of a non-HLA antigen in B-lymphocytes from patients with rheumatic fever and their relatives defined using monoclonal antibodies].
    Rodríguez RS; Ontiveros P; Torres S; Khanna AK; Buskirk DR; Zabriskie JB
    Bol Med Hosp Infant Mex; 1990 May; 47(5):313-7. PubMed ID: 2390184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocytes binding C-reactive protein and streptococcal membranes in acute rheumatic fever.
    Williams RC; van de Rijn I; Mahros F; Abdin ZH; Reid H; Poon-King T
    J Lab Clin Med; 1980 Nov; 96(5):803-14. PubMed ID: 7419963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The diagnostic significance of the surface B-cell marker carrier state in arthritis and other manifestations of rheumatic fever].
    Shostak NA
    Ter Arkh; 1991; 63(5):49-52. PubMed ID: 1887418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease.
    Gibofsky A; Khanna A; Suh E; Zabriskie JB
    J Rheumatol Suppl; 1991 Aug; 30():1-5. PubMed ID: 1941846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
    Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
    J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of HL-A antigen phenotype in rheumatic fever and rheumatic heart disease patients.
    Falk JA; Fleischman JL; Zabriskie JB; Falk RE
    Tissue Antigens; 1973; 3(3):173-8. PubMed ID: 4771172
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunological studies on acute rheumatic fever and rheumatic heart disease.
    Boonpucknavig S; Udomsangpetch R; Pongpanich B
    J Clin Lab Immunol; 1984 Mar; 13(3):133-6. PubMed ID: 6609239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethnic differences in expression of susceptibility marker(s) in rheumatic fever/rheumatic heart disease patients.
    Kaur S; Kumar D; Grover A; Khanduja KL; Kaplan EL; Gray ED; Ganguly NK
    Int J Cardiol; 1998 Mar; 64(1):9-14. PubMed ID: 9579811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in Lymphocyte cell surface markers in human disease states.
    Williams RC
    Clin Immunol Rev; 1981-1982; 1(3):409-69. PubMed ID: 6762279
    [No Abstract]   [Full Text] [Related]  

  • 17. Potency analysis of inactivated vaccines for Aujeszky's disease virus (ADV), strain RC/79: lymphocyte stimulation in immunized pigs.
    Sabini LI; Ceriatti F; Torres C; Sutil S; Lara L; Rovera M; Ramos B; Rodriguez MI
    Rev Latinoam Microbiol; 2001; 43(3):123-9. PubMed ID: 17061498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the human cellular immune response to purified group A streptococcal blastogen A1.
    Regelmann WE; Gray ED; Wannamaker LW
    J Immunol; 1982 Apr; 128(4):1631-6. PubMed ID: 7037952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheumatic fever: how S. pyogenes-primed peripheral T cells trigger heart valve lesions.
    Guilherme L; Faé KC; Oshiro SE; Tanaka AC; Pomerantzeff PM; Kalil J
    Ann N Y Acad Sci; 2005 Jun; 1051():132-40. PubMed ID: 16126952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity assay against cultured heart cell in rheumatic heart disease.
    Iida N
    Jpn Circ J; 1978 Jul; 42(7):886-92. PubMed ID: 713027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.